Clinical characteristics and treatment of patients with IgA nephropathy and hepatitis B surface antigen

Renal Failure

Volumn 35, Issue 4, 2013, Pages 446-451

  Sun, In O ^a   Hong, Yu Ah ^a   Park, Hoon Suk ^a   Choi, Sun Ryoung ^a   Chung, Byung Ha ^a   Park, Cheol Whee ^a   Yang, Chul Woo ^a   Kim, Yong Soo ^a   Choi, Bum Soon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Anti viral therapy; Hepatitis B; IgA nephropathy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; CHOLESTEROL; CORTICOSTEROID; CREATININE; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PROTEIN; URIC ACID; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; URIC ACID BLOOD LEVEL; URINARY EXCRETION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; GUANINE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALE; MIDDLE AGED;

EID: 84876351457     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.775659     Document Type: Article

References (20)

1. Rifai A, Millard K. Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA. Clin Exp Immunol. 1985;60:363-368
2. Lai KN, Lai FM, Tam JS, Vallence-Owen J. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol. 1988;29:229-234
3. Iida H, Izumino K, Asaka M, Fujita M, Takata M, Ig SS. A nephropathy and hepatitis B virus. Nephron. 1990;54:18-20
4. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 1990;37:663-676
5. Wang NS,WuZL, Zhang YE, Guo MY, Liao LT. Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy. World J Gastroenterol. 2005;11:712-716
6. Wang NS, Wu ZL, Zhang YE, Liao LT. Role of hepatitis B virus infection in pathogenesis of IgA nephropathy. World J Gastroenterol. 2003;9:2004-2008
7. Endo Y, Kanabayashi H. Etiology of IgA nephropathy syndrome. Pathol Int. 1994;44:1-3
8. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol. 2004;24:197-217
9. Galla JH. IgA nephropathy. Kidney Int. 1995;47:377-387
10. Lai KN, Li PK, Lui SF, et al. Membranous nephropathy related to hepatitis B virus-associated nephropathy in adults. N Engl J Med. 1991;324:1457-1463
11. Lai KN, Tam JS, Lin HJ, Lai FM. Therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron. 1990;54:12-17
12. Tang S, Lai FM, Lui YH, et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int. 2005;68:1750-1758
13. Levey AS, Greene T, Kusek JW. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:A0828
14. Lai KN, Lai FM, Tam JS. Comparison of polyclonal and monoclonal antibodies in determination of glomerular deposits of hepatitis B virus antigens in hepatitis B virusassociated glomerulonephritides. Am J Clin Pathol. 1989;92:159-165
15. Ig SR. A mesangial nephropathy: Berger's disease. Am J Nephrol. 1985;5:73-83
16. Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver disease in Korea: Hepatitis B. Korean J Hepatol. 2009;15: S13-S24
17. Ito H, Harrori S, Matsuda I, et al. Hepatitis B e antigen mediated membranous glomerulonephritis. Lab Invest. 1981;44:214-220
18. Lai AS, Lai KN. Viral nephropathy. Nat Clin Pract Nephrol. 2006;2:254-262
19. Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157-163
20. Ballardie FW, Roberts ISD. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol. 2002;13:142-148